FDA
-
-
-
-
-
-
-
PMGC Holdings Inc. [NASDAQ: ELAB] Reports 2025 Annual Results and Files Form 10-K, Company Expands Asset Base to $13.8M, a 43% Increase from 2024
-
-
-
-
-
-
-
Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1
-
-
-
-
329,073 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

